Ads
related to: list of tpa drugs for cancer deaths- Programs & Services
Helping Patients Get The Support
They So Desperately Deserve & Need.
- What Is Prostate Cancer?
Learn more about prostate cancer.
Types of prostate cancer.
- Give In Honor & Memorial
Honor A Loved One With A Donation.
Support Those Touched By Cancer.
- Prostate Cancer Toolkit
Learn more about prostate cancer.
View our recommended resources.
- Programs & Services
cancer.osu.edu has been visited by 10K+ users in the past month
Search results
Results From The WOW.Com Content Network
Alteplase, sold under the brand name Activase among others, is a biosynthetic form of human tissue-type plasminogen activator (t-PA). It is a thrombolytic medication used to treat acute ischemic stroke, acute ST-elevation myocardial infarction (a type of heart attack), pulmonary embolism associated with low blood pressure, and blocked central venous catheter. [5]
The tPA which was then secreted into the culture medium was isolated and collected for therapeutic use. For pharmaceutical purposes, tPA was the first pharmaceutical drug produced synthetically with the use of mammalian cells, specifically Chinese hamster ovarian cells . Recombinant tPA is commonly referred to as r-tPA and sold under multiple ...
Thus, TPA/PMA has been routinely used as an inducer for endogenous superoxide production. [5] TPA is also being studied as a drug in the treatment of hematologic cancer [citation needed] TPA has a specific use in cancer diagnostics as a B-cell specific mitogen in cytogenetic testing. Cells must be divided in a cytogenic test to view the ...
This is a list of chemotherapeutic agents, also known as cytotoxic agents or cytostatic drugs, that are known to be of use in chemotherapy for cancer.This list is organized by type of agent, although the subsections are not necessarily definitive and are subject to revision.
Plasminogen activator inhibitor-1 is a serine protease, synthesized by endothelial cells, that specifically inhibits tissue plasminogen activator (tPA) and urokinase (uPA). Tissue plasminogen activator and urokinase are the activators of plasminogen and result in the breakdown of blood clots ( fibrinolysis ).
Non-small cell lung cancer, oesophageal cancer, uterine cervical cancer, head and neck cancer and urothelial cancer: Nephrotoxicity, myelosuppression and nausea and vomiting (30-90%). Oxaliplatin: IV: Reacts with DNA, inducing apoptosis, non-cell cycle specific. Colorectal cancer, oesophageal cancer and gastric cancer